Who Owns Harbin Pharmaceutical Group Co., Ltd.?
Updated onExplore the ownership hierarchy of Harbin Pharmaceutical Group Co., Ltd.. See parent companies, holding structures, and ultimate controllers.
Ownership Chain
Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned pharmaceutical conglomerate that integrates research and development, manufacturing, trade, and distribution of medicines, health products, and traditional Chinese medicine.
Harbin Pharmaceutical Group Co., Ltd. appears to be independent with no known parent company.
Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a Chinese partially state-owned pharmaceutical conglomerate that integrates research and development, manufacturing, trade, and distribution of medicines, health products, and traditional Chinese medicine.
Harbin Pharmaceutical Group Co., Ltd. appears to be independent with no known parent company.
Major Shareholders
Harbin Pharmaceutical Group Co., Ltd.
Major Shareholders
| Name | Type | Ownership | Voting | As of |
|---|---|---|---|---|
Harbin Pharmaceutical Group Co., Ltd. (哈药集团有限公司) Controlling shareholder and unlisted parent/holding company of the listed Harbin Pharmaceutical Group Co., Ltd. (SSE:600664). | Corporate | 46.6% | 46.6% | Sep 2025 |
China Securities Investor Protection Fund Co., Ltd. (中国证券投资者保护基金有限责任公司) State-backed investor protection fund holding A-shares directly. | Government | 2.2% | 2.2% | Sep 2025 |
Hong Kong Securities Clearing Company Ltd. (香港中央结算有限公司) Nominee/clearing holder for overseas and Hong Kong investors in A-shares. | Institutional | 1.0% | 1.0% | Sep 2025 |
Xia Zhongyang (夏重阳) Direct individual shareholder. | Individual | 0.9% | 0.9% | Sep 2025 |
Yu Hongbiao (余宏标) Direct individual shareholder. | Individual | 0.7% | 0.7% | Sep 2025 |
China Merchants Bank Co., Ltd. – Southern CSI 1000 ETF (招商银行股份有限公司-南方中证1000交易型开放式指数证券投资基金) Exchange-traded fund holding A-shares via custodial account at China Merchants Bank. | Institutional | 0.6% | 0.6% | Sep 2025 |
Harbin Tianxiang Weiye Investment Co., Ltd. (哈尔滨天翔伟业投资有限公司) Local investment company shareholder. | Corporate | 0.5% | 0.5% | Sep 2025 |
Xiamen Fucheng Financing Guarantee Co., Ltd. (厦门富诚融资担保有限公司) Corporate shareholder providing financing guarantees; holds A-shares directly. | Corporate | 0.3% | 0.3% | Sep 2025 |
China Merchants Bank Co., Ltd. – Huaxia CSI 1000 ETF (招商银行股份有限公司-华夏中证1000交易型开放式指数证券投资基金) Exchange-traded fund shareholder holding A-shares via China Merchants Bank. | Institutional | 0.3% | 0.3% | Sep 2025 |
Industrial and Commercial Bank of China – GF CSI 1000 ETF (中国工商银行股份有限公司-广发中证1000交易型开放式指数证券投资基金) Exchange-traded fund shareholder holding A-shares via ICBC. | Institutional | 0.3% | 0.3% | Sep 2025 |
Get Started
Your ultimate competitive playbook
You just found your top competitors. Now let's map your whole landscape and show you how to stand out.
Competitive Landscape Report
Built for small teams who can't hire a full-time analyst.
$129 $260 one-time payment
Generated in minutes, no subscription.
Instead of guessing what to do about your competitors, get a done-for-you intelligence report
Competitor Map
Direct, indirect, and alternative competitors mapped across your market
Positioning Analysis
How each competitor positions, their ICP, and key differentiators
Feature & Pricing Matrix
Side-by-side comparison of features, pricing, and packaging strategies
Growth Channel Analysis
SEO, paid ads, content, and social strategies across the landscape
Reputation & Social Proof
Ratings, reviews, and sentiment analysis across all competitors
90-Day Action Plan
Specific tactics to differentiate and win more deals in the next 3 months